<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="1f5d1d5c-9c71-4243-8bc5-5c04b2847af5"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Pablo Neruda</title>
  <effectiveTime value="20260615120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="62e11574-c0c7-41be-911c-29a3e2394f9c"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="99c79178-214d-4693-8243-e7dcc8c23f68" extension="HR-ML051-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-51-2976"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Pablo</given><family>Neruda</family></name>
        <administrativeGenderCode code="M" codeSystem="2.16.840.1.113883.5.1" displayName="Male"/>
        <birthTime value="19590712"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260615120000-0500"/>
    <assignedAuthor><id root="2ad01890-e418-47b2-8970-ed004845c4ff"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Marisol</given><family>Fairweather-Diaz</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260615120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="2ad01890-e418-47b2-8970-ed004845c4ff"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Marisol</given><family>Fairweather-Diaz</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20260615"/><high value="20260615"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="2ad01890-e418-47b2-8970-ed004845c4ff"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Marisol</given><family>Fairweather-Diaz</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="ccbf1436-f719-4f35-9c51-df54ca1efaf5"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Two-week review with the medical oncology consultation the same day: biopsy and staging results, the diagnosis, shared decision on treatment, the start of apalutamide, genetic testing, and bone density</originalText></code>
      <effectiveTime><low value="20260615"/><high value="20260615"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="2ad01890-e418-47b2-8970-ed004845c4ff"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Marisol</given><family>Fairweather-Diaz</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Two-week review: biopsy and staging results; medical oncology seen today. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mr. Neruda returns two weeks after his first visit, with a professional Spanish interpreter. In the past ten days he had an MRI of the prostate, a targeted biopsy at the urology practice, a CT scan, a bone scan and a PSMA PET/CT. The results were explained to him this morning by Dr. Okonkwo-Lund of medical oncology and again today: prostate cancer, Gleason 4+4, that has spread to two lymph nodes in the pelvis and to two places in the bones, the right hip bone and the lowest lumbar vertebra, with nothing in the lungs, liver or other organs. He chose, after hearing the options, to start apalutamide today, with a leuprolide injection in one week and radiotherapy to the prostate in about six weeks. His blood was drawn today for germline genetic testing after counseling. He had his bone density scan this morning. The right hip pain is a little better on acetaminophen, 5 of 10 at worst, and still wakes him some nights; he has no leg weakness, numbness, or change in bladder or bowel control. His urinary symptoms are unchanged. He feels the news is hard but says he would rather know. He wants to keep writing every morning and to continue his duties. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Diagnosis</td><td>Prostate adenocarcinoma, Gleason 4+4 (Grade Group 4), 9 of 14 cores</td></tr><tr><td>Staging</td><td>Two pelvic lymph nodes and two bone metastases (right ilium, L5); no visceral disease: low volume</td></tr><tr><td>Decision</td><td>Apalutamide from today, leuprolide in one week, radiotherapy to the prostate; no docetaxel</td></tr><tr><td>Starting today</td><td>Apalutamide 240 mg daily; cholecalciferol 2000 units daily</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Negative</td><td>No weight loss, fever or night sweats</td></tr><tr><td>Genitourinary</td><td>Positive</td><td>Frequency, weak stream and nocturia three times, unchanged; no blood in the urine</td></tr><tr><td>Musculoskeletal</td><td>Positive</td><td>Right hip and low back pain, 5 of 10 at worst on acetaminophen</td></tr><tr><td>Neurological</td><td>Negative</td><td>No leg weakness, numbness or saddle numbness; no change in bladder or bowel control</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Worried but coping; PHQ-2 score 1</td></tr></tbody></table><paragraph>5 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Amlodipine 5 mg oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>2021-04-06 to 2026-07-13</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Acetaminophen 500 mg oral tablet, two tablets (1000 mg) up to three times daily as needed for bone pain</td><td>Two tablets up to three times daily as needed</td><td>Oral route</td><td>2026-06-01 to 2026-09-14</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Apalutamide 240 mg oral tablet, one tablet once daily, swallowed whole, with or without food</td><td>One tablet once daily</td><td>Oral route</td><td>2026-06-15</td><td>active</td><td>S</td></tr><tr ID="medication-6"><td>Cholecalciferol (vitamin D3) 2000 units (0.05 mg) oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>2026-06-15</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="9730a304-4e84-4ee0-95ae-e3d57201e4de"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20210406"/><high value="20260713"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197361" codeSystem="2.16.840.1.113883.6.88" displayName="amlodipine 5 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="03b78115-2bdf-496d-8ec0-b23f169187ab"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I10" codeSystem="2.16.840.1.113883.6.90" displayName="Essential (primary) hypertension"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="9c9c6102-50a3-41a9-b24d-f7bf9c21354a"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260601"/><high value="20260914"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="2"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198440" codeSystem="2.16.840.1.113883.6.88" displayName="acetaminophen 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="b4588fdf-39bb-4955-957a-521a2b888623"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R97.20" codeSystem="2.16.840.1.113883.6.90" displayName="Elevated prostate specific antigen [PSA]"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="fd8a77dc-4a0c-4536-93da-d3d235acba34"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C79.51" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary malignant neoplasm of bone"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="7c588d54-4c52-4d23-9b88-248b8bb1c2db"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260615"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="2630215" codeSystem="2.16.840.1.113883.6.88" displayName="apalutamide 240 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="113e638d-c0fb-4b64-af15-85f04dfa06e2"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C61" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of prostate"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="8df557ed-d9e3-4d13-bde0-d41d289d9304"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z19.1" codeSystem="2.16.840.1.113883.6.90" displayName="Hormone sensitive malignancy status"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="f39931f9-893b-4ae8-9724-8eb762d139cf"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.899" codeSystem="2.16.840.1.113883.6.90" displayName="Other long term (current) drug therapy"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="2cff4a50-2a6c-49dd-aff2-478b85c8abdf"/>
      <text><reference value="#medication-6"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260615"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="801663" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.05 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="984a35aa-324e-456a-be8a-0c28d4f17cda"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="5e74bd0b-bdf8-4e72-900a-1db3fc360faa"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="M85.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified disorders of bone density and structure, multiple sites"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="1b33dad6-fc53-4bbc-bb2c-96498a1ca55b"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260601"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="16799c55-09bf-4762-88f8-1754b5f60aba"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-2-1"><td>2026-06-15</td><td>Body height</td><td>178</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-2-2"><td>2026-06-15</td><td>Body weight</td><td>92</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-2-3"><td>2026-06-15</td><td>Body mass index (BMI) [Ratio]</td><td>29</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-2-4"><td>2026-06-15</td><td>Systolic blood pressure</td><td>142</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-5"><td>2026-06-15</td><td>Diastolic blood pressure</td><td>86</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-6"><td>2026-06-15</td><td>Heart rate</td><td>74</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-7"><td>2026-06-15</td><td>Respiratory rate</td><td>14</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-8"><td>2026-06-15</td><td>Body temperature</td><td>36.6</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-2-9"><td>2026-06-15</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>97</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="2676053d-14d7-4d3b-8935-6b313a3adaa1"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20260615"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="93daa038-0fa6-4b23-aa00-0cea89a3e102"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-2-1"/></text><statusCode code="completed"/><effectiveTime value="20260615"/><value xsi:type="PQ" value="178" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="cb68e1fb-3a85-44bb-96e4-8af3d7af0164"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-2-2"/></text><statusCode code="completed"/><effectiveTime value="20260615"/><value xsi:type="PQ" value="92" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="6a0ff960-a447-466c-ad0d-9b8ce830fd3d"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-2-3"/></text><statusCode code="completed"/><effectiveTime value="20260615"/><value xsi:type="PQ" value="29" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="6ca81e9d-5a0c-400e-bae9-c66d29162ebb"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-2-4"/></text><statusCode code="completed"/><effectiveTime value="20260615"/><value xsi:type="PQ" value="142" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="7ce1a4f8-9844-414c-9443-324e4d88f053"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-2-5"/></text><statusCode code="completed"/><effectiveTime value="20260615"/><value xsi:type="PQ" value="86" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="61b8221a-d31e-42d5-882a-0d5497879676"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-2-6"/></text><statusCode code="completed"/><effectiveTime value="20260615"/><value xsi:type="PQ" value="74" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="0feda4b0-5a83-4cb1-9528-b091e46bf256"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-2-7"/></text><statusCode code="completed"/><effectiveTime value="20260615"/><value xsi:type="PQ" value="14" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="18ab3e6b-6c28-421d-b12e-1151ae2ada60"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-2-8"/></text><statusCode code="completed"/><effectiveTime value="20260615"/><value xsi:type="PQ" value="36.6" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="2e1b230c-2dd5-4352-b7c3-e2d9e16e9c2d"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-2-9"/></text><statusCode code="completed"/><effectiveTime value="20260615"/><value xsi:type="PQ" value="97" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-26"><td>2026-06-15</td><td>DXA Femur [T-score] Bone density</td><td>-2.1</td><td>{T-score}</td><td>-1.0 or higher is normal; -2.5 or lower is osteoporosis</td><td>Low</td><td>S</td></tr>
  <tr ID="result-27"><td>2026-06-15</td><td>DXA Lumbar spine [T-score] Bone density</td><td>-1.4</td><td>{T-score}</td><td>-1.0 or higher is normal; -2.5 or lower is osteoporosis</td><td>Low</td><td>S</td></tr>
  <tr ID="result-28"><td>2026-06-15</td><td>Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]</td><td>1</td><td>{score}</td><td></td><td></td><td>S</td></tr>
  <tr ID="result-29"><td>2026-06-15</td><td>Pain severity - 0-10 verbal numeric rating [Score] - Reported</td><td>5</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="34533018-b7bd-4237-97ce-31417e2954a8"/>
      <code code="38263-0" codeSystem="2.16.840.1.113883.6.1" displayName="DXA Femur [T-score] Bone density"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260615"/><high value="20260615"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="1d45cc8e-d30a-45b1-851a-dd94cc87039d"/>
          <code code="38263-0" codeSystem="2.16.840.1.113883.6.1" displayName="DXA Femur [T-score] Bone density"/>
          <text><reference value="#result-26"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260615"/>
          <value xsi:type="PQ" value="-2.1" unit="{T-score}"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>-1.0 or higher is normal; -2.5 or lower is osteoporosis</text>
              <value xsi:type="IVL_PQ"><low value="-1" unit="{T-score}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="f1afd9e6-652c-4c2e-8201-df7f6c2cac23"/>
      <code code="38267-1" codeSystem="2.16.840.1.113883.6.1" displayName="DXA Lumbar spine [T-score] Bone density"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260615"/><high value="20260615"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="bbf27c2c-7257-4487-b06c-d1b8af0a5487"/>
          <code code="38267-1" codeSystem="2.16.840.1.113883.6.1" displayName="DXA Lumbar spine [T-score] Bone density"/>
          <text><reference value="#result-27"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260615"/>
          <value xsi:type="PQ" value="-1.4" unit="{T-score}"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>-1.0 or higher is normal; -2.5 or lower is osteoporosis</text>
              <value xsi:type="IVL_PQ"><low value="-1" unit="{T-score}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="9e44f668-c650-44a3-86d6-ceed9db80be1"/>
      <code code="55758-7" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260615"/><high value="20260615"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="229538d5-9de7-4dd0-9c6d-cda66ef8e3ce"/>
          <code code="55758-7" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"/>
          <text><reference value="#result-28"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260615"/>
          <value xsi:type="PQ" value="1" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="6ca6ea78-26f3-45ae-a188-e8183d3ebab3"/>
      <code code="72514-3" codeSystem="2.16.840.1.113883.6.1" displayName="Pain severity - 0-10 verbal numeric rating [Score] - Reported"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260615"/><high value="20260615"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="78e80dbc-7fe9-49a9-98f6-29702951bdd8"/>
          <code code="72514-3" codeSystem="2.16.840.1.113883.6.1" displayName="Pain severity - 0-10 verbal numeric rating [Score] - Reported"/>
          <text><reference value="#result-29"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260615"/>
          <value xsi:type="PQ" value="5" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-06-15; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; walks without help, favoring the right hip slightly</td></tr><tr><td>Cardiovascular</td><td>Regular rhythm; blood pressure 142/86 mm Hg; no ankle swelling</td></tr><tr><td>Musculoskeletal</td><td>Tender over the right iliac crest; no midline spinal tenderness</td></tr><tr><td>Neurological</td><td>Strength 5 of 5 in both legs; sensation and knee and ankle reflexes normal</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Urinary frequency, weak stream and nocturia for four months, with right hip and low back pain for six weeks, a hard nodular prostate and a raised PSA; suspected prostate cancer, to be confirmed</td><td>resolved</td><td>confirmed</td>
    <td>R97.20</td><td>S — Synthetic presenting problem, resolved at the second visit when biopsy and staging established metastatic prostate cancer.</td>
  </tr>
  <tr ID="problem-2">
    <td>Adenocarcinoma of the prostate, Grade Group 4 (Gleason 4+4), cT3a N1 M1b, de novo metastatic hormone-sensitive disease, low volume by conventional imaging (two bone metastases, in the right ilium and L5, and two pelvic lymph nodes; no visceral disease); synthetic modern detail linked to his documented prostate cancer of 1971</td><td>active</td><td>confirmed</td>
    <td>C61</td><td>S — Synthetic grade, stage, extent and PSA; the prostate cancer and the operation in France in 1971 are documented (D), and no stage, grade or treatment detail was found in the sources read.</td>
  </tr>
  <tr ID="problem-3">
    <td>Bone metastases from prostate cancer: right iliac wing (painful) and L5 vertebral body; no cord compression</td><td>active</td><td>confirmed</td>
    <td>C79.51</td><td>S — Synthetic metastatic sites.</td>
  </tr>
  <tr ID="problem-4">
    <td>Pelvic lymph node metastases: right external iliac and right obturator nodes</td><td>active</td><td>confirmed</td>
    <td>C77.5</td><td>S — Synthetic nodal disease.</td>
  </tr>
  <tr ID="problem-5">
    <td>Hormone-sensitive prostate cancer</td><td>active</td><td>confirmed</td>
    <td>Z19.1</td><td>S — Synthetic status in the modern episode.</td>
  </tr>
  <tr ID="problem-6">
    <td>Continuous androgen deprivation (leuprolide) with apalutamide, with monitoring of testosterone, PSA, thyroid function, blood pressure, glucose and lipids, bone health, rash, falls, hot flashes, sexual health, mood and cognition</td><td>active</td><td>confirmed</td>
    <td>Z79.899</td><td>S — Synthetic treatment plan; Z79.899 is used because ICD-10-CM has no specific code for GnRH agonist therapy.</td>
  </tr>
  <tr ID="problem-7">
    <td>Essential hypertension for five years, on amlodipine</td><td>active</td><td>confirmed</td>
    <td>I10</td><td>S — Synthetic comorbidity, relevant to cardiovascular risk on androgen deprivation; not a claim about his real blood pressure.</td>
  </tr>
  <tr ID="problem-8">
    <td>Vitamin D insufficiency (25-hydroxyvitamin D 22 ng/mL)</td><td>active</td><td>confirmed</td>
    <td>E55.9</td><td>S — Synthetic finding at intake, addressed at the second visit.</td>
  </tr>
  <tr ID="problem-9">
    <td>Low bone mass (femoral neck T-score -2.1, L1 to L4 -1.4) with a ten-year hip fracture risk above 3% (FRAX, with androgen deprivation counted as a cause of secondary osteoporosis)</td><td>active</td><td>confirmed</td>
    <td>M85.89</td><td>S — Synthetic bone-health finding on the DXA before androgen deprivation.</td>
  </tr>
  <tr ID="problem-10">
    <td>Prediabetes (hemoglobin A1c 5.9%)</td><td>active</td><td>confirmed</td>
    <td>R73.03</td><td>S — Synthetic metabolic finding at intake, relevant to androgen deprivation.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="06213280-05b7-4a76-8360-f1e535e4f719"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260601"/><high value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="5112a268-4540-48de-ab40-413567ee1ad7"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260601"/><high value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="R97.20" codeSystem="2.16.840.1.113883.6.90" displayName="Elevated prostate specific antigen [PSA]"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="9ef1d279-23f7-4d71-b143-98f38f542f67"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="b755d6ed-cafd-466a-a5b8-df2289d7cb9e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="C61" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of prostate"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="7aa74503-110b-4e98-9d55-06da473749e1"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="bd8664aa-5b48-4cdb-a434-91a661ce58f4"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="C79.51" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary malignant neoplasm of bone"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="986bc96b-beab-4736-9864-6a1cb53c29e2"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="8955d24d-f179-47b3-b2a5-0ea0e1d69e1d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="C77.5" codeSystem="2.16.840.1.113883.6.90" displayName="Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="067c7dd9-edc4-42ad-95dc-81b34bab100f"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="10630a94-da0d-4a51-b37d-0a0298749465"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-5"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="Z19.1" codeSystem="2.16.840.1.113883.6.90" displayName="Hormone sensitive malignancy status"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="818def5c-cba2-4751-b1ae-9fe3884c0754"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="844e88e1-3f30-4dac-8c4d-e85d5d290528"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-6"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="Z79.899" codeSystem="2.16.840.1.113883.6.90" displayName="Other long term (current) drug therapy"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="0d487f33-5e29-4c4b-8202-5304a26040b5"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260601"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="958429b7-c197-4805-9f51-ba322e0c7581"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-7"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260601"/></effectiveTime>
          <value xsi:type="CD" code="I10" codeSystem="2.16.840.1.113883.6.90" displayName="Essential (primary) hypertension"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="78a78346-da33-4860-b6c8-454c53e16f0c"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="ec0b5de1-92d6-4853-89eb-870ec212e3dd"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-8"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="084b1bd6-b360-4e77-b379-c62ab3421e2d"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260615"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="f50ec7e7-216c-4abc-ab1d-5b875d300ef4"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-9"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260615"/></effectiveTime>
          <value xsi:type="CD" code="M85.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified disorders of bone density and structure, multiple sites"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="87fb2c72-6e49-4338-a3c5-30da25963cfa"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260601"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="a019aac6-da29-49d7-b170-56aa3080dd23"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-10"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260601"/></effectiveTime>
          <value xsi:type="CD" code="R73.03" codeSystem="2.16.840.1.113883.6.90" displayName="Prediabetes"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Metastatic hormone-sensitive prostate cancer, Grade Group 4, cT3a N1 M1b, low volume (C61)</content>. De novo metastatic disease, low volume on conventional imaging (two bone metastases, both in the spine and pelvis, and no visceral disease), confirmed by PSMA PET/CT. The plan follows the consultation today: androgen deprivation with an androgen receptor pathway inhibitor, plus radiotherapy to the prostate for low-volume disease. Docetaxel is not added, because its survival benefit is in high-volume disease. [S]<list><item>Apalutamide 240 mg once daily from today.</item><item>Leuprolide 22.5 mg in one week at the oncology clinic, then every twelve weeks; apalutamide started a week before covers the testosterone flare.</item><item>Radiotherapy to the prostate, 55 Gy in 20 fractions, about six weeks after starting.</item><item>Germline testing sent today; somatic testing of the biopsy tissue requested.</item></list></item><item><content styleCode="Bold">Bone metastases (right ilium, L5) (C79.51)</content>. Pain improving on acetaminophen; no signs of spinal cord compression. Androgen deprivation usually eases bone pain within weeks. [S]<list><item>Acetaminophen 1000 mg up to three times a day.</item><item>Warning signs of cord compression reviewed again in Spanish, with a written card.</item></list></item><item><content styleCode="Bold">Low bone mass before androgen deprivation (M85.89)</content>. Femoral neck T-score -2.1 and L1 to L4 -1.4. FRAX, counting androgen deprivation as a cause of secondary osteoporosis, gives a ten-year hip fracture risk of 3.4 percent and a major osteoporotic fracture risk of 13 percent; the hip risk is above the 3 percent threshold for a bone-protective drug. [S]<list><item>Dental examination before denosumab.</item><item>Denosumab 60 mg every six months, the osteoporosis dose, once calcium is confirmed normal and vitamin D is being replaced.</item><item>Calcium 1000 to 1200 mg a day from food; walking and resistance exercise.</item></list></item><item><content styleCode="Bold">Vitamin D insufficiency (E55.9)</content>. 25-hydroxyvitamin D 22 ng/mL. [S]<list><item>Cholecalciferol 2000 units daily from today; recheck in four weeks before denosumab.</item></list></item><item><content styleCode="Bold">Hypertension (I10)</content>. 142/86 mm Hg, above goal. Apalutamide is a strong CYP3A4 inducer and is expected to lower amlodipine levels. [S]<list><item>Blood pressure at the four-week visit; amlodipine dose to be adjusted then.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Laboratory</td><td>PSA before treatment</td><td>Baseline, then every 3 to 6 months on androgen deprivation</td><td>Up to date</td><td>46.8 ng/mL at the first visit</td></tr><tr><td>Laboratory</td><td>Testosterone</td><td>Baseline, then every 3 to 6 months on androgen deprivation (target below 50 ng/dL)</td><td>Up to date</td><td>468 ng/dL at the first visit</td></tr><tr><td>Laboratory</td><td>Blood count, chemistry, alkaline phosphatase and LDH</td><td>Baseline in metastatic disease</td><td>Up to date</td><td>Hemoglobin 13.6 g/dL; creatinine 0.96 mg/dL; alkaline phosphatase 168 U/L (raised); LDH 208 U/L; calcium 9.6 mg/dL</td></tr><tr><td>Laboratory</td><td>TSH before apalutamide</td><td>Baseline, then periodically on apalutamide</td><td>Ordered</td><td>Ordered today before the first dose</td></tr><tr><td>Laboratory</td><td>Hemoglobin A1c and lipid panel</td><td>Baseline and yearly on androgen deprivation</td><td>Up to date</td><td>A1c 5.9 percent and LDL 140 mg/dL at the first visit</td></tr><tr><td>Laboratory</td><td>Calcium and 25-hydroxyvitamin D</td><td>Baseline and periodically on androgen deprivation and bone-protective drugs</td><td>Up to date</td><td>Calcium 9.6 mg/dL and vitamin D 22 ng/mL at the first visit; cholecalciferol starts today</td></tr><tr><td>Imaging</td><td>Bone density (DXA) with FRAX</td><td>Baseline before androgen deprivation, then every 1 to 2 years</td><td>Completed today</td><td>Femoral neck T-score -2.1; L1 to L4 -1.4; FRAX hip 3.4 percent, major osteoporotic 13 percent</td></tr><tr><td>Imaging</td><td>Staging: CT, bone scan and PSMA PET/CT</td><td>At diagnosis</td><td>Up to date</td><td>Completed in the past ten days; low volume on conventional imaging; PSMA PET/CT concordant</td></tr><tr><td>Examination</td><td>Blood pressure and cardiovascular assessment</td><td>Every visit on androgen deprivation</td><td>Completed today</td><td>142/86 mm Hg; no chest pain or breathlessness</td></tr><tr><td>Examination</td><td>Neurological check for spinal cord compression</td><td>Every visit with spinal metastases</td><td>Completed today</td><td>Normal leg strength, sensation and reflexes; no bladder or bowel change</td></tr><tr><td>Survey</td><td>Distress and depression screen (PHQ-2)</td><td>At diagnosis and at intervals</td><td>Completed today</td><td>PHQ-2 score 1</td></tr><tr><td>Survey</td><td>Pain score</td><td>Every visit with symptomatic metastases</td><td>Completed today</td><td>5 of 10 at worst on acetaminophen, down from 6</td></tr><tr><td>Survey</td><td>Urinary symptoms (IPSS)</td><td>Baseline before treatment, then every follow-up visit</td><td>Up to date</td><td>IPSS 17 at the first visit; unchanged</td></tr><tr><td>Survey</td><td>Sexual function</td><td>Baseline before treatment and periodically</td><td>Completed today</td><td>Reviewed before androgen deprivation; loss of libido and erections explained</td></tr><tr><td>Survey</td><td>Cognition</td><td>Periodically on androgen deprivation</td><td>Due</td><td>Mini-Cog at the annual wellness visit</td></tr><tr><td>Medication safety</td><td>Testosterone flare protection</td><td>When starting a GnRH agonist with bone metastases</td><td>Completed today</td><td>Apalutamide starts today, one week before leuprolide</td></tr><tr><td>Medication safety</td><td>Drug interactions with apalutamide</td><td>When starting and with any new medicine</td><td>Completed today</td><td>Strong CYP3A4 inducer: amlodipine levels expected to fall; blood pressure check in four weeks</td></tr><tr><td>Medication safety</td><td>Falls and fracture risk on apalutamide</td><td>Every visit on androgen deprivation</td><td>Completed today</td><td>No falls; counseled on rugs, lighting and night-time walking</td></tr><tr><td>Referral</td><td>Medical oncology (genitourinary)</td><td>Once, then through treatment</td><td>Completed today</td><td>Seen today; recommendations in the consultation note</td></tr><tr><td>Referral</td><td>Germline genetic testing with counseling</td><td>Once, for metastatic disease</td><td>Completed today</td><td>Counseled and blood drawn today; result in two to three weeks</td></tr><tr><td>Referral</td><td>Radiation oncology for radiotherapy to the prostate</td><td>Once</td><td>Ordered</td><td>Planning visit in about four weeks</td></tr><tr><td>Self-management</td><td>Physical activity, calcium intake, no tobacco, and care in Spanish</td><td>Every visit</td><td>Completed today</td><td>Walking as pain allows; calcium from food; written plan in Spanish</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Diagnosis, staging and a shared treatment decision within three weeks of the first visit. Outcome by 2026-06-15: Biopsy, CT, bone scan and PSMA PET/CT within ten days; apalutamide started at the consultation two weeks after intake [S]</item><item>Bone pain controlled, with a pain score of 2 or less and sleep restored. In progress; target 2026-07-13 [S]</item><item>PSA of 0.2 ng/mL or less within about seven months of starting treatment. In progress; target 2026-09-14 [S]</item><item>Blood pressure below 130/80 mm Hg on androgen deprivation. In progress; target 2026-10-05 [S]</item><item>Protect bone health: 25-hydroxyvitamin D of 30 ng/mL or more, calcium from food, weight-bearing exercise, and a bone-protective drug for high fracture risk. In progress; target 2026-10-05 [S]</item><item>Keep his morning writing and his official duties through treatment. In progress; target 2026-10-05 [S]</item></list><paragraph>Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (2026); Advanced Prostate Cancer: AUA/SUO Guideline, first published 2020 and amended 2023 and 2026 (2026); ERLEADA (apalutamide) tablets: prescribing information (2026); CMID: Clinical Monitoring Intelligence Database, prostate cancer and hypertension monographs (2026)</paragraph><paragraph>Follow-up: Leuprolide at the oncology clinic in one week. Dental examination before the next visit. Review in four weeks with PSA, testosterone, chemistry, vitamin D and blood pressure. Next scheduled visit 2026-07-13: four-week review on apalutamide and leuprolide: early PSA response, testosterone, blood pressure, pain, the dental check and the first denosumab dose, and the radiotherapy plan. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
